0001209191-22-046956.txt : 20220819 0001209191-22-046956.hdr.sgml : 20220819 20220819200009 ACCESSION NUMBER: 0001209191-22-046956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220817 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TREACE JAMES T CENTRAL INDEX KEY: 0001185191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 221181920 MAIL ADDRESS: STREET 1: 117 BRISTOL PLACE CITY: PONTE VEDRA BEACH STATE: FL ZIP: 32082 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 471052611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-17 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001185191 TREACE JAMES T 203 FORT WADE ROAD SUITE 150 PONTE VEDRA FL 32081 1 0 0 0 Common Stock 2022-08-17 4 S 0 15954 19.54 D 1220487 D Common Stock 2022-08-18 4 S 0 34046 19.09 D 1186441 D Common Stock 556183 I By Spouse The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.0200 to $19.9000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.3400 to $19.2950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Lisa Taylor as Attorney-in-fact for James T. Treace 2022-08-19